Recombinant human Eph receptor B2 protein (ab60851)



  • NatureRecombinant
  • SourceBaculovirus infected Sf9 cells
  • Amino Acid Sequence
    • SpeciesHuman
    • Molecular weight66 kDa
    • TagsGST tag N-Terminus
    • Additional sequence informationRecombinant fragment, corresponding to amino acids 570-end of Human Eph receptor B2 (cytoplasmic domain).

Associated products


Our Abpromise guarantee covers the use of ab60851 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Biological activity

    Specific Activity: 39 nmol/min/mg.

  • Applications


    Functional Studies

  • FormLiquid
  • Additional notes

    ab204877 (Poly (4:1 Glu, Tyr) peptide) can be utilized as a substrate for assessing kinase activity

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    Preservative: None
    Constituents: 25% Glycerol, 50mM Tris HCl, 150mM Sodium chloride, 0.25mM DTT, 0.1mM EGTA, 0.1mM EDTA, 0.1mM PMSF, pH 7.5

    This product is an active protein and may elicit a biological response in vivo, handle with caution.

General Info

  • Alternative names
    • cek5
    • Developmentally regulated EPH related tyrosine kinase
    • DRT
    • EK5
    • ELK related protein tyrosine kinase
    • Eph receptor B2
    • EPH tyrosine kinase 3
    • EPH-like kinase 5
    • EPHB2
    • Ephrin type B receptor 2
    • Ephrin type-B receptor 2
    • EPHT 3
    • ERK
    • ETECK
    • hEK5
    • Nuk
    • Prkm 5
    • Receptor protein tyrosine kinase HEK 5
    • Renal carcinoma antigen NY-REN-47
    • Sek 3
    • Tyro 5
    • Tyrosine protein kinase receptor CEK 5
    • Tyrosine protein kinase receptor EPH 3
    • Tyrosine protein kinase receptor QEK 5
    • Tyrosine-protein kinase receptor EPH-3
    • Tyrosine-protein kinase TYRO5
    see all
  • FunctionReceptor for members of the ephrin-B family. Phosphorylates ARHGEF15, leading to its ubiquitination and degradation by the proteasome which promotes EFNB1-dependent synapse formation. Can function in aspects of retinal ganglion cell axon guidance to the optic disk even when lacking its tyrosine kinase domain. Acts as a tumor suppressor.
  • Tissue specificityBrain, heart, lung, kidney, placenta, pancreas, liver and skeletal muscle. Preferentially expressed in fetal brain.
  • Involvement in diseaseDefects in EPHB2 may be a cause of susceptibility to prostate cancer (PC) [MIM:176807]. It is a malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. Note=EPHB2 mutations have been found in a prostate cancer cell line derived from a brain metastasis.
  • Sequence similaritiesBelongs to the protein kinase superfamily. Tyr protein kinase family. Ephrin receptor subfamily.
    Contains 2 fibronectin type-III domains.
    Contains 1 protein kinase domain.
    Contains 1 SAM (sterile alpha motif) domain.
  • Cellular localizationMembrane.
  • Information by UniProt

Recombinant human Eph receptor B2 protein images

  • Sample Kinase Activity Plot.
  • ab60851 on SDS-PAGE, MW ~66 kDa.

References for Recombinant human Eph receptor B2 protein (ab60851)

ab60851 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab60851.
Please use the links above to contact us or submit feedback about this product.